To some extent, this hypothesis is confirmed by the data showing that the results of surgical treatment of congenital heart disease are worse in patients with increased levels of galectin-3 than in those with normal plasma concentrations of the protein [25]. This evidence concerns the gene LGALS3 and congenital heart disease.